Indoco Remedies Limited has informed the Exchange regarding a press release dated May 23, 2025, titled "Indoco Remedies receives final approval from the USFDA for Allopurinol Tablets USP 200 mg".
Indoco Remedies Limited has informed the Exchange regarding a press release dated May 23, 2025, titled "Indoco Remedies receives final approval from the USFDA for Allopurinol Tablets USP 200 mg".